Literature DB >> 33642885

Smoking and COVID-19: A Literature Review of Cohort Studies in Non-Chinese Population Settings.

Aoife Rodgers1, Manasi Nadkarni1, Emilie Kruke Indreberg1, Lenah Alfallaj1, Zubair Kabir1.   

Abstract

BACKGROUND: Smoking history and its potential association with COVID-19 has attracted many researchers and the lay public alike. However, the studies published to date have several methodological limitations and are mainly from China. We set out to synthesize evidence on smoking and COVID-19 relationship drawn on cohort studies only which are published in non-Chinese population settings.
METHOD: A systematic literature search was undertaken drawn on predefined eligibility criteria and a comprehensive search strategy following the PRISMA guideline between January 2020 and August 2020, excluding preprints and gray literature. Three specific outcomes were examined: smoking history, SARS-CoV2 infection, and COVID-19 severity.
RESULTS: Of an eligible 40 full-text studies, 7 cohort studies outside of China were finally included in this literature review through independent reviewing. Four studies were from the UK, 2 from the United States, and 1 from Turkey. The sample size ranged from 200 to more than 5000 participants. The findings broadly point to 1 direction, a higher smoking prevalence and an increased risk of smoking history on both SARS-CoV2 infection and on COVID-19 severity.
CONCLUSION: A smoking history (either current or past) seems to negatively impact both SARS-CoV2 infection and COVID-19 severity. However, such an observation strengthens the argument to continue smoking cessation efforts both for individuals and for the general population health and well-being.
© The Author(s) 2021.

Entities:  

Keywords:  COVID-19; Smoking; prospective; review; severity

Year:  2021        PMID: 33642885      PMCID: PMC7841696          DOI: 10.1177/1179173X20988671

Source DB:  PubMed          Journal:  Tob Use Insights        ISSN: 1179-173X


  17 in total

1.  A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.

Authors:  Jean-Pierre Changeux; Zahir Amoura; Felix A Rey; Makoto Miyara
Journal:  C R Biol       Date:  2020-06-05       Impact factor: 1.583

Review 2.  Smoking, SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice.

Authors:  Emily J Grundy; Taiba Suddek; Filippos T Filippidis; Azeem Majeed; Sophie Coronini-Cronberg
Journal:  Tob Induc Dis       Date:  2020-07-03       Impact factor: 2.600

Review 3.  Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis.

Authors:  Konstantinos Farsalinos; Anastasia Barbouni; Konstantinos Poulas; Riccardo Polosa; Pasquale Caponnetto; Raymond Niaura
Journal:  Ther Adv Chronic Dis       Date:  2020-06-25       Impact factor: 5.091

4.  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

Authors:  Nicole M Kuderer; Toni K Choueiri; Dimpy P Shah; Yu Shyr; Samuel M Rubinstein; Donna R Rivera; Sanjay Shete; Chih-Yuan Hsu; Aakash Desai; Gilberto de Lima Lopes; Petros Grivas; Corrie A Painter; Solange Peters; Michael A Thompson; Ziad Bakouny; Gerald Batist; Tanios Bekaii-Saab; Mehmet A Bilen; Nathaniel Bouganim; Mateo Bover Larroya; Daniel Castellano; Salvatore A Del Prete; Deborah B Doroshow; Pamela C Egan; Arielle Elkrief; Dimitrios Farmakiotis; Daniel Flora; Matthew D Galsky; Michael J Glover; Elizabeth A Griffiths; Anthony P Gulati; Shilpa Gupta; Navid Hafez; Thorvardur R Halfdanarson; Jessica E Hawley; Emily Hsu; Anup Kasi; Ali R Khaki; Christopher A Lemmon; Colleen Lewis; Barbara Logan; Tyler Masters; Rana R McKay; Ruben A Mesa; Alicia K Morgans; Mary F Mulcahy; Orestis A Panagiotou; Prakash Peddi; Nathan A Pennell; Kerry Reynolds; Lane R Rosen; Rachel Rosovsky; Mary Salazar; Andrew Schmidt; Sumit A Shah; Justin A Shaya; John Steinharter; Keith E Stockerl-Goldstein; Suki Subbiah; Donald C Vinh; Firas H Wehbe; Lisa B Weissmann; Julie Tsu-Yu Wu; Elizabeth Wulff-Burchfield; Zhuoer Xie; Albert Yeh; Peter P Yu; Alice Y Zhou; Leyre Zubiri; Sanjay Mishra; Gary H Lyman; Brian I Rini; Jeremy L Warner
Journal:  Lancet       Date:  2020-05-28       Impact factor: 79.321

5.  Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.

Authors:  Naci Şenkal; Rasimcan Meral; Alpay Medetalibeyoğlu; Hilal Konyaoğlu; Murat Kose; Tufan Tukek
Journal:  Anatol J Cardiol       Date:  2020-07       Impact factor: 1.596

6.  COVID-19 and associations with frailty and multimorbidity: a prospective analysis of UK Biobank participants.

Authors:  S J Woolford; S D'Angelo; C Cooper; N C Harvey; E M Curtis; C M Parsons; K A Ward; E M Dennison; H P Patel
Journal:  Aging Clin Exp Res       Date:  2020-07-23       Impact factor: 3.636

7.  Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York.

Authors:  Leonidas Palaiodimos; Damianos G Kokkinidis; Weijia Li; Dimitrios Karamanis; Jennifer Ognibene; Shitij Arora; William N Southern; Christos S Mantzoros
Journal:  Metabolism       Date:  2020-05-16       Impact factor: 8.694

8.  Renin-Angiotensin-Aldosterone System Blockers Are Not Associated With Coronavirus Disease 2019 (COVID-19) Hospitalization: Study of 1,439 UK Biobank Cases.

Authors:  Zahra Raisi-Estabragh; Celeste McCracken; Maddalena Ardissino; Mae S Bethell; Jackie Cooper; Cyrus Cooper; Nicholas C Harvey; Steffen E Petersen
Journal:  Front Cardiovasc Med       Date:  2020-07-14

9.  Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19.

Authors:  Lara Jehi; Xinge Ji; Alex Milinovich; Serpil Erzurum; Amy Merlino; Steve Gordon; James B Young; Michael W Kattan
Journal:  PLoS One       Date:  2020-08-11       Impact factor: 3.240

Review 10.  The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7).

Authors:  David Simons; Lion Shahab; Jamie Brown; Olga Perski
Journal:  Addiction       Date:  2020-11-17       Impact factor: 7.256

View more
  2 in total

1.  COVID-19 patients with documented alcohol use disorder or alcohol-related complications are more likely to be hospitalized and have higher all-cause mortality.

Authors:  Kristina L Bailey; Harlan Sayles; James Campbell; Neha Khalid; Madyson Anglim; Jana Ponce; Todd A Wyatt; James C McClay; Ellen L Burnham; Alfred Anzalone; Corrine Hanson
Journal:  Alcohol Clin Exp Res       Date:  2022-05-02       Impact factor: 3.928

2.  Reactions to Pictorial and Text Cigarette Pack Warning Labels among Chinese Smokers.

Authors:  Liu Wang; Xi Yao; Gang Wang; Kecheng Du
Journal:  Int J Environ Res Public Health       Date:  2022-09-07       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.